Commonwealth Equity Services’s Yarrow Bioscience YARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-366
Closed -$11.9K – 4569
2026
Q2
$11.9K Hold
366
– – ﹤0.01% 4395
2026
Q1
$10.9K Hold
366
– – ﹤0.01% 4277
2025
Q4
$10.6K Hold
366
– – ﹤0.01% 4262
2025
Q3
$6K Hold
366
– – ﹤0.01% 4229
2025
Q2
$30K Hold
366
– – ﹤0.01% 4201
2025
Q1
$29K Hold
366
– – ﹤0.01% 4107
2024
Q4
$61K Hold
366
– – ﹤0.01% 3969
2024
Q3
$34K Buy
+366
New +$34.7K ﹤0.01% 3966
2022
Q1
– Sell
-22
Closed -$20K – 3809
2021
Q4
$20K Hold
22
– – ﹤0.01% 3601
2021
Q3
$27K Buy
22
+1
+5% +$1.94K ﹤0.01% 3535
2021
Q2
$65K Hold
21
– – ﹤0.01% 3443
2021
Q1
$127K Hold
21
– – ﹤0.01% 3233
2020
Q4
$122K Sell
21
-8
-28% -$50.3K ﹤0.01% 3033
2020
Q3
$172K Hold
29
– – ﹤0.01% 2774
2020
Q2
$179K Buy
29
+1
+4% +$6.77K ﹤0.01% 2643
2020
Q1
$265K Buy
28
+1
+4% +$15.7K ﹤0.01% 2156
2019
Q4
$450K Buy
+27
New +$450K ﹤0.01% 2000

Other funds holding YARW

Commonwealth Equity Services's YARW Position: Q3 2026 in Review

Commonwealth Equity Services sold out of Yarrow Bioscience (YARW) in Q3 2026, closing a stake of 366 shares — an estimated $11.9K sold.

Commonwealth Equity Services first reported a position in YARW in Q4 2019 and held it in 17 quarters. The position peaked at $450K in Q4 2019. 50 funds tracked by Wall St. Rank hold YARW as of Q3 2026.

  • Commonwealth Equity Services reported no remaining Yarrow Bioscience position as of Q3 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 366 Yarrow Bioscience shares in Q3 2026, an estimated $11.9K.
  • Commonwealth Equity Services first reported a position in Yarrow Bioscience in Q4 2019 and held it in 17 quarters.
  • Commonwealth Equity Services's Yarrow Bioscience position peaked at $450K in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.

Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.